Besides, SARS-CoV-2 might attack the ACE2-expressed pancreatic islets to impair the endocrine balance, and the ensuing insulin deficiency/resistance could cause hyperglycemia as other non-COVID-19 critical illness did (23, 24). Here, ACE2 is linked to COVID-19.